BUZZ-Outset Medical rises after FDA clears upgraded dialysis system

Reuters
01/27
BUZZ-Outset Medical rises after FDA clears upgraded dialysis system

** Shares of medical device maker Outset Medical OM.O rise 8% to $5.30 premarket

** Co says the U.S. FDA cleared its next-generation dialysis system, Tablo, which has added reliability features

** Adds that Tablo's upgraded cybersecurity meets the FDA's latest standards

** Tablo is used for hemodialysis — a treatment that filters waste from the blood when kidneys fail

** Co says hardware and software updates are aimed at cutting maintenance needs and improving durability in hospitals

** Shipments of the new system to begin in Q2 2026; existing users can upgrade

** Shares fell ~78% in 2025

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10